Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Archie A Silver

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 14, 2002
A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorderR Douglas Shytle, Archie A Silver, Berney J Wilkinson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 11, 2003
Ziprasidone-induced oculogyric crisisAmaya E Ramos, R Douglas Shytle, Archie A Silver, et al.
Depression and Anxiety|November 5, 2002
Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamineR Douglas Shytle, Archie A Silver, Kathy H Sheehan, et al.
Assessment|September 25, 2003
The Tourette's Disorder Scale (TODS): development, reliability, and validityR Douglas Shytle, Archie A Silver, Kathy Harnett Sheehan, et al.
Human Genetics|April 17, 2003
Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorderFiona C Crawford, Ghania Ait-Ghezala, Mark Morris, et al.
Journal of Neurochemistry|April 2, 2004
Cholinergic modulation of microglial activation by alpha 7 nicotinic receptorsR Douglas Shytle, Takashi Mori, Kirk Townsend, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 14, 2002
A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorderR Douglas Shytle, Archie A Silver, Berney J Wilkinson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|September 11, 2003
Ziprasidone-induced oculogyric crisisAmaya E Ramos, R Douglas Shytle, Archie A Silver, et al.
Depression and Anxiety|November 5, 2002
Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamineR Douglas Shytle, Archie A Silver, Kathy H Sheehan, et al.
Assessment|September 25, 2003
The Tourette's Disorder Scale (TODS): development, reliability, and validityR Douglas Shytle, Archie A Silver, Kathy Harnett Sheehan, et al.
Human Genetics|April 17, 2003
Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorderFiona C Crawford, Ghania Ait-Ghezala, Mark Morris, et al.
Journal of Neurochemistry|April 2, 2004
Cholinergic modulation of microglial activation by alpha 7 nicotinic receptorsR Douglas Shytle, Takashi Mori, Kirk Townsend, et al.
Pageof 1